Once again, significant differences were found when comparing the red fluorescent dots in the controls and individuals diagnosed with MS; the prefrontal cortex of patients showed a greater amount of CB2R-GPR55 heteromers compared to that observed in the controls (Figure 2A,B). This evidence concerns the gene GPR55 and myeloid sarcoma.